AFC
APGE icon

Ares Financial Consulting’s Apogee Therapeutics APGE Stock Holding History

Ares Financial Consulting’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99K Buy
+15
New +$1.35K ﹤0.01% 886

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Ares Financial Consulting's APGE Position: Q2 2026 in Review

Ares Financial Consulting opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 15 shares worth $1.99K. The stake represents ﹤0.01% of the portfolio and ranks #886 among its holdings.

6 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Ares Financial Consulting held 15 shares of Apogee Therapeutics worth $1.99K as of Q2 2026.
  • Apogee Therapeutics was a new Ares Financial Consulting position in Q2 2026.
  • Apogee Therapeutics made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #886 holding.
  • 6 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.